Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

LeMaitre to Participate in Upcoming Investor Conferences

By GlobeNewswire

BURLINGTON, Mass., Nov. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

Stifel 2026 Healthcare Conference
Thursday, November 12, 2026
New York, NY
Dorian LeBlanc, CFO, will present at 8:00 AM EST

Jefferies 2026 Global Healthcare Conference
Tuesday, November 17, 2026
London, UK
Dorian LeBlanc, CFO, will present at 10:30 AM GMT

Piper Sandler 38th Annual Healthcare Conference
Thursday, December 3, 2026
New York, NY
Dorian LeBlanc, CFO, will present at 8:30 AM EST

About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.

Contact:

Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.